Biohaven Ltd. Common Shares (BHVN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Biohaven Ltd. Common Shares, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$15.52
+1.50% today
Market cap
$2.3B
Overall quality
31/100
Kronos AI 30-day
−12.7%
0 of 8 simulated paths end higher
Biohaven Ltd. Common Shares (BHVN) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $2.3B. It trades at $15.52, up 1.50% today. Its overall quality score is 31 out of 100, ranked against the whole US market. 12 analysts' average target of $23.11 implies +48.9% from today's price. Kronos AI's 30-day forecast is −12.7% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $23.11 |
| Low – high | $10.00 – $48.00 |
| Analysts | 12 |
| Upside to average | +48.9% |
Kronos AI 30-day forecast
| Expected close | $13.35 (−12.7%) |
| Likely range | −14.7% … −8.7% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
| Profitability | 34 |
| Solvency | 21 |
| Growth | 39 |
| Overall | 31 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.